BILL ANALYSIS �
------------------------------------------------------------
|SENATE RULES COMMITTEE | SCR 17|
|Office of Senate Floor Analyses | |
|1020 N Street, Suite 524 | |
|(916) 651-1520 Fax: (916) | |
|327-4478 | |
------------------------------------------------------------
UNFINISHED BUSINESS
Bill No: SCR 17
Author: La Malfa (R)
Amended: 9/1/11
Vote: 21
SENATE FLOOR : 37-0, 8/22/11
AYES: Alquist, Anderson, Berryhill, Blakeslee, Cannella,
Corbett, Correa, De Le�n, DeSaulnier, Dutton, Emmerson,
Evans, Fuller, Gaines, Hancock, Harman, Hernandez, Huff,
Kehoe, La Malfa, Leno, Lieu, Liu, Lowenthal, Negrete
McLeod, Padilla, Pavley, Price, Rubio, Runner, Simitian,
Steinberg, Vargas, Walters, Wolk, Wright, Yee
NO VOTE RECORDED: Calderon, Strickland, Wyland
ASSEMBLY FLOOR : 76-0, 9/7/11 - See last page for vote
SUBJECT : Prostate Cancer Awareness Month
SOURCE : Author
DIGEST : This resolution designates the month of
September 2011 as
Prostate Cancer Awareness Month in the State of California.
Assembly Amendments update the statistics on prostate
cancer to reflect the most current data available and make
minor technical changes.
ANALYSIS : Resolution findings:
CONTINUED
SCR 17
Page
2
1. Prostate cancer impacts all Californians and has touched
the Senate of the State of California last year with the
passing of Senator Dave Cox after a 13-year battle with
the disease.
2. The American Cancer Society estimates that one in six
men will develop prostate cancer in their lifetime.
Approximately 240,890 new cases of the disease in the
United States are predicted for 2011, resulting in
nearly 33,720 deaths.
3. In California, prostate cancer is the most common cancer
among men in all race and ethnic groups. African
American men are more likely to develop this disease
than any other group of men.
4. In California, approximately 25,030 men are predicted to
be diagnosed with prostate cancer in 2010 and each day
more than eight California men will die of this disease.
5. While prostate cancer is a leading cause of cancer
deaths in men, little is known about this disease and
there are usually no symptoms in the early stages.
6. The survival rate approaches 100 percent when prostate
cancer is diagnosed and treated early, but drops to 31
percent when the disease spreads to other parts of the
body.
7. A prostate-specific antigen (PSA) blood test and a
digital rectal examination (DRE) diagnose most prostate
cancers before symptoms develop.
8. The American Cancer Society recommends that health care
providers offer the PSA and DRE to men who have at least
a 10-year life expectancy, beginning when the men are 50
years of age.
9. Men who have a father, son, or brother who has been
diagnosed with prostate cancer before 65 years of age,
and African American men should be offered a PSA and DRE
beginning when they are 45 years of age.
10. Men who have multiple family members who have been
CONTINUED
SCR 17
Page
3
diagnosed with prostate cancer before 65 years of age
should be offered a PSA and DRE beginning when they are
40 years of age.
FISCAL EFFECT : Fiscal Com.: No
ASSEMBLY FLOOR : 76-0, 9/7/11
AYES: Achadjian, Alejo, Allen, Ammiano, Atkins, Beall,
Bill Berryhill, Block, Blumenfield, Bradford, Brownley,
Buchanan, Butler, Charles Calderon, Campos, Carter,
Cedillo, Chesbro, Conway, Cook, Davis, Dickinson,
Donnelly, Eng, Feuer, Fletcher, Fong, Fuentes, Beth
Gaines, Galgiani, Garrick, Gatto, Gordon, Grove, Hagman,
Halderman, Hall, Harkey, Hayashi, Roger Hern�ndez, Hill,
Huber, Hueso, Huffman, Jeffries, Jones, Knight, Lara,
Logue, Bonnie Lowenthal, Ma, Mansoor, Mendoza, Miller,
Monning, Morrell, Nestande, Nielsen, Norby, Olsen, Pan,
Perea, V. Manuel P�rez, Portantino, Silva, Skinner,
Smyth, Solorio, Swanson, Torres, Valadao, Wagner,
Wieckowski, Williams, Yamada, John A. P�rez
NO VOTE RECORDED: Bonilla, Furutani, Gorell, Mitchell
CTW:kc 9/8/11 Senate Floor Analyses
SUPPORT/OPPOSITION: NONE RECEIVED
**** END ****
CONTINUED